E lectro m ag n etics B ranch, D ivision of E le ctro n ic P ro d u cts B ureau of R adiological H ealth, Food and Drug A d m inistration ABSTRACT An electro en cep h alo g rap h (EEG) is one of the m ost sen sitiv e m ed ical devices in u s e --it resp o n d s to m icro v o lt lev els of b ra in wave p o te n tia ls. Can indicative EMC te stin g be co n ducted using the ra d ia te d field stre n g th levels set fo rth in the EMC Standard fo r M edical D e v ices ? Does the patient act as an effective a n tenna; o r, could a su b stitu te electro n ic patient be u sed ? Is it p o ssib le to identify the su sc e p tible EEG com ponents 2 If so, can re la tiv e ly cost effective shielding of th ese com ponents be developed to im prove the E E G 's o v erall EMC to rad iated fie ld s? T hese and o ther a s p ects w ere con sid ered and re so lv e d o v er the freq u en cy range fro m 50 kHz to 110 MHz.
INTRODUCTION
The Food and D rug A d m in istra tio n 's B ureau of R adiological H ealth (BRH) has conducted la b o ra to ry te s ts on a c u rre n t production m odel EEG to d eterm in e th is d e v ic e 's su scep tib ility to r a d iated electro m ag n etic signals in the frequency range of 50 kHz to 110 MHz. T his was done in cooperation with the FD A 's B ureau of M edical D evices (BMD) in support of th e ir developm ent of a stan d ard on electro m ag n etic com patibility (EMC) fo r m edical devices.
The BRH receiv ed a re q u e st fro m the V e te ra n s' A d m in istratio n (VA) to evaluate EEG equipm ent fo r com pliance with the proposed FDA EMC stan d ard . The VA req u ested the te stin g to gain a quantitative insight as to the amount of e x te r n a l rad io freq u en cy (rf) shielding that is n e c e s s a r y to obtain an in te rfe re n c e -fre e EEG r e c o r d ing in a hospital environm ent (Ref. 1). The VA policy, at that tim e , was to in sta ll rf-sh ield ed ro o m s in each a re a in which EEG would be used during the co n stru ctio n of a new hospital. If the r f in te rfe re n c e c h a ra c te ris tic s fo r an EEG d e vice, one of the m o re sen sitiv e m edical in s tr u m en ts, w ere known, a b e tte r indication of the degree of shielding n e c e s s a ry could be d e te r m ined. T his could re s u lt in substantial cost reduction.
PROCEDURE
With the cooperation of a m a jo r EEG m an u fa c tu re r, EMC te s ts w ere conducted on an eight channel EEG using passiv e loads, a BRH d ev el oped o p tically -d riv en electro n ic substitute p a tient, and th re e hum an v olunteers. The p assive loads te ste d w ere: 10 k and 24 k re s is to r s ; th e se r e s is to r s in p a ra lle l with 0. 1 m ic ro fara d cap a cito rs; and com binations of th e se r e s is to r s and ca p ac ito rs with diodes. During p re lim in a ry testin g , the 10 k r e s is to r s proved to be the best p a ssiv e load; how ever, since no "b rain wave" w as being generated, one could not be su re if the EEG re c o rd was in terfe ren ce free o r if it a p p ea red so due to com plete am p lifier saturation.
(In e ith e r case, a stra ig h t line "EEG re c o rd " would be o b s e rv e d .) T his led to the developm ent of an active ele ctro n ic substitute patient which consisted of a light pulsed photodiode in p a ra lle l with a 10 k r e s is to r (figs. 1 & 2). The gate in d ica to r light of a frequency counter was found to be a suitable light source to pulse the photodiode. Its light p ulses w ere optically coupled to the pho todiode via a tw enty foot (6. 1 m e te rs) light pipe; thereby, keeping the size of the electro n ic su b stitute patient, and its field p ertu rb atio n poten tia l, m inim al. The electro n ic substitute p a tie n t's "brain w ave" appeared as a continuous wave (CW) signal on the EEG re c o rd and was s im ila r in both frequency and am plitude to the hum an alpha wave (i. e . , 50 m icro v o lts peakpeak at 8-13 Hz). A balanced p a ra lle l plate tra n s m is s io n line, driv en with high pow er rf a m p lifie rs, was sele cte d fo r generation of the r f exposure fields.
The te s t sp e c tru m was divided into nine swept frequency bands. This allowed the field leveling equipm ent (consisting of an E -field U.S. G overnm ent work not p ro te cte d by U.S. copyright.
se n s o r o p tically coupled to a lev elin g p r e a m p li fier) to be p re c is e ly o p era ted so that the te s t s u b ject would not be exposed to le v e ls h igher than intended. T he o p tical-lev e lin g cable w as also the m e c h a n ism by w hich the hum an vo lu n teer, o r the EEG technician, could at w ill im m ed iate ly t e r m i nate the r f ex p o su re field during the te s ts . (See fig u re 3 fo r a photograph of the ex p o su re s e t -u p . ) F ig u re 1: Com ponent p a r ts of the "E le ctro n ic S ubstitute P atie n t" . F ig u re 2: A ssem b led "E le ctro n ic Substitute P atien t". Multi -conductor cable F ig u re 3: RF ex p o su re se t-u p with p a r a lle l plate tra n s m is s io n line so u rc e , E -fie ld leveling s e n s o r, EEG, and c h a ir fo r hum an volunteer. 
RESULTS
T h is investigation indicated the following f o r the freq u en cy ran g e tested:
1.
An elec tro n ic su b stitu te patient, p ro v id ed it is n o n -p ertu rb in g , can validly re p la c e a hum an subject to te s t an EEG fo r ra d ia te d e l e c tro m a g n e tic su sc ep tib ility . 2. T his EEG unit w as su scep tib le to in t e r fe re n c e at c e r ta in fre q u en c ies in som e of the te s t-fre q u e n c y bands, while it functioned n o r m a lly in o th e rs. (At th e se specific in te rfe re n c e fre q u en c ies, the FDA EMC S tandard (Ref. 2) could not be s a tis f ie d .) B ased on th e se r e s u lts , it a p p e a rs that p r io r knowledge of the am bient ele c tro m a g n e tic en v ironm ent (i. e. , field stre n g th and frequency) at a proposed building site, for exam ple, could m odify the d e g re e of shielding n e c e s s a r y fo r unaffected op eratio n of the EEG.
3. E ach of the eight ch a n n e l's a m p lifie rs " p ro c e s s e d " the rf in te rfe rin g signal differently at a given in te rfe re n c e frequency. T his can be se e n in fig u re 4, at 22 MHz, fo r exam ple. The a m p lifie r fo r channel 7 (second tr a c e fro m the bottom of the rec o rd ) disp lay s le s s in te rfe re n c e than the a m p lifie r for channel 3 (third tr a c e fro m the top of the rec o rd ). P h y sic a lly interchanging the two a m p lifie rs, (i.e . , placing a m p lifie r 7 in channel 3 's slot in the EEG console, and a m p li f ie r 3 in channel 7 's slot), with nothing e lse changed, re su lte d in a r e v e r s e d EEG re c o rd for th e se two channels. T he m in im u m in te rfe re n c e now ap p e are d in the th ird tr a c e fro m the top. The " p ro c e sse d in te rfe re n c e sig n al" follow ed the a m p lifier; th e re fo re , the a m p lif ie r's in te rn a l c h a r a c te ris tic s , r a th e r than its location in the EEG console, d eterm in e d the d e g re e of in te rfe re n c e displayed on the EEG re c o rd . 4, T he p r im a ry r e c e iv e r of r f energy, o v e r the frequency ran g e te ste d , w as found to be the m u lti-co n d u c to r cable (see fig. 3 ) w hich c o n n e c ts the EEG console to the p atient elec tro d e board. A dditional te s ts , using a tr a n s v e r s e e l e c tro m a g n e tic (TEM) tr a n s m is s io n ce ll to expose only the m u lti-co n d u c to r cable, co n firm ed th is by c o m p ariso n with the EEG r e c o rd s obtained fro m the p r im a ry ex p o su re se t-u p . T he TEM ce ll also provided an additional se t of data with which to c o m p are the su sc ep tib ility of the o rig in a l singleshielded m u lti-co n d u c to r cable w ith d o u b le -sh ie ld ed m u lti-co n d u c to r cables, which w ere c o n stru c te d by the EEG m an u factu rer, once it a p p e are d that additional shielding would be b en eficial fo r EMC. 5. Shielding the sm a ll e lec tro d e w ire s (see fig. 1 ), which connect the patient e lec tro d e board to the head of the v o lunteer, (or to the elec tro n ic su b stitu te patient), re su lte d in little, if any, im p ro v em en t in EMC.
6. In g en e ra l, b ased on an o v e ra ll frequency re sp o n se , w hile using the p r im a ry te s t se t-u p , and the TEM ce ll, the following was observed; 
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